James Brumley
James Brumley (RSS)
InvestorPlace Contributor

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He's now primarily a freelance writer, tapping more than a decade's worth of broad experience to help investors get more out of the market.

Read complete bio
Recent Articles

ANF Stock Is Too Long on Risk, Too Short on Reward

Feb. 11, 2015, 12:06 pm EST – Despite being down 65% since late 2011, ANF stock just isn't worth jumping into here. More 

5 ‘Double Threat’ Dividend Stocks That Offer Growth, Too

Feb. 11, 2015, 11:35 am EST – Dividends are nice, but dividend stocks that also offer growth potential leave nothing to be desired. Here are five stocks that offer both dividends and growth. More 

Why Denbury Resources, Freeport-McMoRan and Molson Coors Are 3 of Today’s Worst Stocks

Feb. 10, 2015, 4:44 pm EST – Molson Coors Brewing Company, Denbury Resources and Freeport-McMoRan were the worst of the worst on Tuesday. Here's what investors need to know. More 

What Owners of CVS Stock Need to Know Before Tuesday’s Earnings Report

Feb. 9, 2015, 5:43 pm EST – The CVS Health earnings report for Q4 of 2014 is due Thursday after the close. Here are three things owners of CVS stock need to know beforehand. More 

Why PVH, Century Aluminum and United Continental Holdings Are 3 of Today’s Worst Stocks

Feb. 9, 2015, 4:46 pm EST – United Continental Holdings Inc., Century Aluminum Co. and PVH Corp. were Monday's biggest losers. Here's the deal. More 

Cybersecurity Stocks Are Poised to Reach Full Stride in 2015

Feb. 9, 2015, 10:03 am EST – The planets have lined up for the cybersecurity industry, and the hack of Sony was the proverbial last straw. More 

Why Pandora, Yelp and GoPro Are 3 of Today’s Worst Stocks

Feb. 6, 2015, 4:28 pm EST – Yelp Inc., GoPro Inc. and Pandora Media Inc. ended the week on a pretty low note, thanks largely to bad earnings and outlooks. More 

4 (More) Biotech Stocks to Buy

Feb. 6, 2015, 2:06 pm EST – Jazz Pharmaceuticals, bluebird bio, Illumina and Celgene are the latest batch of biotech stocks worth serious consideration. More 

TWTR Stock Deserves Its Post-Earnings Jump

Feb. 6, 2015, 7:30 am EST – TWTR stock will have a ridiculous valuation for several more years, but valuation was never what Twitter was about. More 

Why Prudential Financial, Teradata and Keurig Green Mountain Are 3 of Today’s Worst Stocks

Feb. 5, 2015, 4:41 pm EST – Keurig Green Mountain, Prudential Financial and Teradata doled out more than their fair share of pain on Thursday. Here's why. More